1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. REPLIGEN CORP.
123.07 1.39 (1.14%)
127.6K
XNAS Volume

XNAS 26 Sep, 2025 11:23 AM (EDT)

Watchlist

Portfolio

Alert

Board Meeting
The latest board meeting for Repligen Corp. took place on 25 Sep 2025, for the purpose of The Bank of America Global Healthcare Conference See details

US Politician trade disclosures for Repligen Corp. from May 8, 2025 to September 26, 2025

Representative Lisa McClain discloses a trade of $1K-15K in Repligen Corp., made on August 13, 2025.

Members of Congress or their families often buy or sell securities and have access to non-public information through their roles. The STOCK Act requires them to report these trades within 45 days to ensure transparency and reduce conflicts of interest.